000 | 01397 a2200409 4500 | ||
---|---|---|---|
005 | 20250517232033.0 | ||
264 | 0 | _c20181003 | |
008 | 201810s 0 0 eng d | ||
022 | _a1879-0631 | ||
024 | 7 |
_a10.1016/j.lfs.2018.07.053 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeng, Bin | |
245 | 0 | 0 |
_aAstragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway. _h[electronic resource] |
260 |
_bLife sciences _cSep 2018 |
||
300 |
_a111-121 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
650 | 0 | 4 |
_aDiabetic Angiopathies _xetiology |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSaponins _xpharmacology |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aToll-Like Receptor 4 _xantagonists & inhibitors |
650 | 0 | 4 |
_aTriterpenes _xpharmacology |
700 | 1 | _aTang, Futian | |
700 | 1 | _aLu, Meili | |
700 | 1 | _aZhang, Zhen | |
700 | 1 | _aWang, Hongxin | |
700 | 1 | _aZhang, Yingjie | |
773 | 0 |
_tLife sciences _gvol. 209 _gp. 111-121 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2018.07.053 _zAvailable from publisher's website |
999 |
_c28703813 _d28703813 |